B Cells in Rheumatoid Arthritis: From Pathogenic Players to Disease Biomarkers
Open Access
- 1 January 2014
- journal article
- review article
- Published by Hindawi Limited in BioMed Research International
- Vol. 2014, 1-14
Abstract
The therapeutic benefit of depleting B cells in rheumatoid arthritis (RA) has refocused attention on B cells with increasing awareness on their role in autoimmunity and their function beyond autoantibody production. The rapid increase in our comprehension of B-cell pathobiology is progressively opening novel perspectives in the area of B cell-targeted therapies with the expectation to define more specific approaches able to preserve the homeostasis of the humoral response while disrupting the pathogenic components. In parallel, B-cell activity in RA is starting to be explored in its clinical value, in search of novel biomarkers embedded in the pathogenic process that could help classifying the disease and predicting its heterogeneous outcome beyond inflammation dynamics. In this review, we summarize current knowledge on the multiple roles that B cells play in several aspects of RA. We also analyze their distribution and potential function in different anatomic compartments with specific reference to the main sites in which the disease may be sustained and exert its detrimental effects: the systemic circulation, synovium, bone marrow, and draining lymph nodes. We also highlight novel data encouraging further research in the field of biomarkers related to B cells and their regulatory factors.Keywords
Funding Information
- Italian Ministry of Health (GR-2009-1608032)
This publication has 129 references indexed in Scilit:
- B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6–producing B cellsJournal of Experimental Medicine, 2012
- Cytokine mRNA profiling identifies B cells as a major source of RANKL in rheumatoid arthritisAnnals of the Rheumatic Diseases, 2011
- The development of inducible bronchus-associated lymphoid tissue depends on IL-17Nature Immunology, 2011
- Facultative role for T cells in extrafollicular Toll-like receptor-dependent autoreactive B-cell responses in vivoProceedings of the National Academy of Sciences, 2011
- Proinflammatory T helper type 17 cells are effective B-cell helpersProceedings of the National Academy of Sciences, 2010
- Mode of action of abatacept in rheumatoid arthritis patients having failed tumour necrosis factor blockade: a histological, gene expression and dynamic magnetic resonance imaging pilot studyAnnals of the Rheumatic Diseases, 2009
- Synovial tissue response to rituximab: mechanism of action and identification of biomarkers of responseAnnals of the Rheumatic Diseases, 2008
- Assessment of rituximab's immunomodulatory synovial effects (ARISE trial). 1: clinical and synovial biomarker resultsAnnals of the Rheumatic Diseases, 2008
- Longitudinal assessment of synovial, lymph node, and bone volumes in inflammatory arthritis in mice by in vivo magnetic resonance imaging and microfocal computed tomographyArthritis & Rheumatism, 2007
- Compromised Function of Regulatory T Cells in Rheumatoid Arthritis and Reversal by Anti-TNFα TherapyJournal of Experimental Medicine, 2004